Novel Strategies to Advance Biotherapeutic Development
Melanie Anderson, MS (she/her/hers)
Principal Scientist
Merck & Co., Inc.
Ambler, Pennsylvania
Patient centric sampling (PCS) involves using novel sample collection approaches to reduce sample volumes, reduce patient burden and increase access to important patient data. These applications are finding increased use in clinical development for PK, biomarker and safety markers.